Zentalis
The Associate Director of Scientific Communications leads the development and execution of global publication strategies and scientific narratives for Zentalis's oncology treatments. This role partners with cross-functional teams and external experts to create high-impact content, manage vendors, and ensure compliance with publication standards while advancing patient care and scientific dialogue.
Zentalis Pharmaceuticals is a clinical-stage oncology company focused on developing azenosertib, a first-in-class oral WEE1 kinase inhibitor, for Cyclin E1-positive platinum-resistant ovarian cancer and other tumor types. The company is advancing azenosertib through late-stage, registration-intended clinical trials, including the Phase 3 ASPENOVA trial, using a biomarker-directed approach to provide a non-chemotherapy targeted therapy option. Zentalis engages the investor and medical communities through detailed pipeline, financial, and governance resources from its headquarters in San Diego, CA.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Zentalis.
Zentalis didn’t post a salary, so this is our estimate from similar listings.
13% above the average for this role
Director, Scientific Communications
kaileratherapeutics
Mgr, Global Scientific Communications
USAJOBS
Scientific Communications Group Lead, Lung
BioLife Plasma Services
Scientific Communications Intern
Elephas
Associate Director, Scientific Communications
BioNTech
Associate Director, Scientific Communications Lead, Hematology, Global Medical Affairs Oncology
Takeda Pharmaceutical Company Limited